The Effects of Erector Spinae Plane Block on Bariatric Surgery.

Sponsor
Karaman Training and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05020379
Collaborator
(none)
80
1
2
12.2
6.6

Study Details

Study Description

Brief Summary

The erector spinae plane block (ESPB) is a new technique that is increasingly used in the treatment of acute and chronic pain. Bariatric surgery is a surgical treatment method used in the treatment of morbid obesity and related comorbidities. Providing pain control in obese patients is a topic that remains up-to-date. Poorly controlled early postoperative pain impairs quality of recovery, increases the risk of postoperative pulmonary complications, and is a risk factor for the subsequent development of chronic pain. Therefore, optimizing acute postoperative analgesia is a priority in patients undergoing bariatric surgery. The primary aim of this prospective, randomized study is to evaluate the effect of ESPB on quality of recovery with the QoR-40 questionnaire in patients undergoing elective Laparoscopic Bariatric Surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Perioperative and postoperative multimodal analgesia
  • Procedure: ESP Block
N/A

Detailed Description

In the operating room, all patients will receive standard monitoring, including electrocardiography, non-invasive blood pressure, and peripheral oxygen saturation. Patients in the ESPB group will be placed in a sitting position. A convex probe ultrasound transducer will be placed in a longitudinal parasagittal orientation approximately 3 cm lateral to the spinous process. The needle tip was advanced until it will be located in the inter-fascial plane deep to the erector spinae muscle group and superior to the transverse process. Once in position, bupivacaine 0.25%, 20 ml was injected under ultrasound, guidance. The same procedure will be repeated on the contralateral site. Standard perioperative and postoperative analgesia protocol will be given and postoperative pain levels will be determined by Numerical Rating Scale (NRS). NRS scores for pain and postoperative opioid consumption will be recorded on the 15th,30th minute, 1st, 2nd, 12th, 24th hour, 2nd day. Quality of recovery-40 (QoR-40) scores will be given on the ward, at postoperative 24th hour, 3rd and 7th day ( the 3rd and 7th-day scores will be calculated after telephone interview if the patient will be discharged from the hospital).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Intervention Model: Parallel AssignmentRandomized Intervention Model: Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Investigation of The Effects of The Erector Spinae Plane Block on The Quality Of Recovery After Laparoscopic Bariatric Surgery: A Prospective Randomized Trial
Actual Study Start Date :
Sep 10, 2021
Anticipated Primary Completion Date :
Aug 15, 2022
Anticipated Study Completion Date :
Sep 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Group N

The patients in Group N will not receive any intervention. Patients will receive standard multimodal analgesia comprising paracetamol, tenoxicam, and tramadol. The pain intensity will be evaluated with the 0-10 Numeric Rating Scale (NRS). NRS are the simple and most commonly used scales.11 The numerical scale is most commonly 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."

Procedure: Perioperative and postoperative multimodal analgesia
Patients will receive standard multimodal analgesia comprising paracetamol, tenoxicam, and tramadol. The pain intensity during rest and motion will be evaluated with the 0-10 Numeric Rating Scale (NRS). NRS scores for pain and postoperative opioid consumption will be evaluated at 15th and 30th minutes, 1st, 2nd, 6th, 12th, 24th hours, 2nd day.
Other Names:
  • Global Quality of Recovery-40 score
  • Standard Pain Follow up
  • Experimental: Group ESPB

    The patients in the group ESPB will be placed in sitting pozition. A convex probe ultrasound transducer will be place in a longitudinal parasagittal orientation about 3 cm lateral to spinous process. Local anesthetic (20 ml 0.25% bupivacaine) will be injected bilaterally into the fascial plane on the deep aspect of erector spinae muscle. Standard perioperative and postoperative analgesia protocol will be given and postoperative pain levels will be determined by Numerical rating scale (NRS)

    Procedure: Perioperative and postoperative multimodal analgesia
    Patients will receive standard multimodal analgesia comprising paracetamol, tenoxicam, and tramadol. The pain intensity during rest and motion will be evaluated with the 0-10 Numeric Rating Scale (NRS). NRS scores for pain and postoperative opioid consumption will be evaluated at 15th and 30th minutes, 1st, 2nd, 6th, 12th, 24th hours, 2nd day.
    Other Names:
  • Global Quality of Recovery-40 score
  • Standard Pain Follow up
  • Procedure: ESP Block
    Patients in the ESPB group will be placed in a sitting position. A convex probe ultrasound transducer will be placed in a longitudinal parasagittal orientation approximately 3 cm lateral to the spinous process. Local anesthetic (20 ml 0.25% bupivacaine) will be injected bilaterally into the fascial plane on the deep face of the erector spinae muscle. Standard perioperative and postoperative analgesia protocol will be given and postoperative pain levels will be determined by Numerical Rating Scale (NRS). NRS scores for pain and postoperative opioid consumption will be evaluated at 15th and 30th minutes, 1st, 2nd, 6th, 12th, 24th hours, 2nd day.
    Other Names:
  • Global Quality of Recovery-40 score
  • Standard Pain Follow up
  • Outcome Measures

    Primary Outcome Measures

    1. Quality of Recovery (QoR-40) score [postoperative 24th hour]

      QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain. Each item is rated on a scale of 1-5, providing a minimum score of 40 and maximum of 200. The increase in scores show high quality of recovery.

    Secondary Outcome Measures

    1. Postoperative pain: numeric rating scale (NRS) [Postoperative 48 hour]

      NRS use numbers to rate pain from 0 (no pain) to 10 (worst pain). Postoperative pain levels will be determined by Numeric Rating Scale (NRS) system

    2. Analgesic consumption [Postoperative 48 hour]

      Total opioid consumption at the postoperative period

    3. Side effects [24 hours]

      Rate of side-effect occurrences (such as rate of vomiting,nausea,dizziness)

    4. Sedation score [Postoperative 48 hour]

      Evaluation of the level of sedation in patients with a 4-point scale (0=wake, 1=sleepy, easy to verbally arouse, 2=drowsy, 3=does not open their eyes to verbal commands).

    5. mobilization time [Postoperative 24 hour]

      The time after surgery to the mobilization of the patient

    6. Quality of Recovery (QoR-40) score [Postoperative 3rd and 7th days]

      QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain. Each item is rated on a scale of 1-5, providing a minimum score of 40 and maximum of 200. The increase in scores show high quality of recovery.

    7. Postoperative complications [Postoperative 30 days]

      Postoperative complications will be identified by visiting patients every day or alternate day during their in hospital course, suplemented by patients medical records using our hospital's electronic patient record database. We will use the Claviene Dindo Classification system from which CC is derived. We defined a postoperative complication as any deviation from the ideal postoperative course, not inherent in the procedure itself and does not constitute a failure to cure. CCI scores willbe calculated using the online CCI calculator.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Scheduled for elective laparoscopic bariatric surgery
    Exclusion Criteria:
    • a history of allergy to local anesthetics

    • known coagulation disorders

    • infection near the puncture site

    • Chronic opioid intake

    • Patient with psychiatric disorders

    • Can not communicate in Turkish

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Karaman Training and Research Hospital Karaman Turkey 70200

    Sponsors and Collaborators

    • Karaman Training and Research Hospital

    Investigators

    • Study Director: Betul Basaran, MD, DESA, Karaman Training and Research Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Karaman Training and Research Hospital
    ClinicalTrials.gov Identifier:
    NCT05020379
    Other Study ID Numbers:
    • 05-2021/05
    First Posted:
    Aug 25, 2021
    Last Update Posted:
    Sep 13, 2021
    Last Verified:
    Sep 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Karaman Training and Research Hospital

    Study Results

    No Results Posted as of Sep 13, 2021